In previous studies we have shown that low concentrations of CgA can reduce the trans-endothelial migration of other malignant cells, such as TSA mammary adenocarcinoma and B16 melanoma cells, by enhancing endothelial VE-cadherin dependent adherence junctions [20, 28]. This evidence concerns the gene CDH5 and melanoma.